Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanoma. Peri A, Greenstein E, Alon M, Pai JA, et al. J Clin Invest 2021;131.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Peri A, Greenstein E, Alon M, Pai JA, et al. Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanoma. J Clin Invest 2021;131.
PMID: 34651586